Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.

PSA values after HIFU treatment

Oncological outcomes will be assessed using PSA measurements obtained as part of routine care. The outcome will be reported as PSA values measured during follow-up after HIFU treatment.

Time frame: From HIFU treatment up to 5 years post-HIFU

Incidence of local recurrence detected by prostate MRI after HIFU treatment

Local recurrence will be assessed using prostate MRI performed as part of routine care. The outcome will be reported as the number and proportion of patients with imaging findings suspicious for local recurrence.

Time frame: From HIFU treatment up to 5 years post-HIFU

Prostate biopsy results after HIFU treatment

Oncological outcomes will be assessed using prostate biopsy results obtained as part of routine care. The outcome will be reported as the number and proportion of patients with positive biopsy findings during follow-up after HIFU treatment.

Time frame: From HIFU treatment up to 5 years post-HIFU

To estimate the retreatment rate of patients treated with HIFU

The rate and timing of retreatment (radical prostatectomy, radiotherapy, cryotherapy, HIFU, other focal treatment) after HIFU treatment will be assessed using data from the patient's clinical follow-up.

Time frame: From HIFU treatment up to 5 years post-HIFU